NIA is excited to announce its #1 favorite biotechnology stock suggestion: Algernon Pharmaceuticals Inc. (CSE: AGN)
AGN's largest shareholder AlphaNorth Asset Management increased their stake in AGN yesterday to 13%!
AGN is preparing to Launch a Phase 1 Study of DMT for the treatment of stroke!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from AGN of US$100,000 cash for a twelve-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.